What is the proper protocol for conducting a water deprivation test to diagnose diabetes insipidus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Water Deprivation Test Protocol for Diagnosing Diabetes Insipidus

The water deprivation test should be conducted as a combined outpatient and inpatient overnight protocol to safely and effectively diagnose patients with polyuria-polydipsia syndrome, differentiating between central diabetes insipidus, nephrogenic diabetes insipidus, and primary polydipsia. 1

Initial Assessment Before Testing

  • Measure baseline serum sodium, serum osmolality, urine volume, and urine osmolality 2
  • Consider measuring plasma copeptin levels as a surrogate marker for AVP - levels <21.4 pmol/l should prompt testing for AVP deficiency (central DI) 2, 3
  • Rule out other causes of polyuria including poorly controlled diabetes mellitus (check for hyperglycemia and glucosuria) 4
  • Genetic testing may help distinguish between central DI and nephrogenic DI, especially in cases with partial AVP insensitivity 4, 3

Water Deprivation Test Protocol

Preparation Phase

  • Discontinue medications that can affect water metabolism (diuretics, prostaglandin inhibitors) at least 24 hours before the test 4
  • Ensure normal sodium diet (≤6 g/day) for several days before testing 4
  • Establish baseline weight, serum sodium, serum osmolality, and urine osmolality 1

Test Execution

  1. Outpatient Phase:

    • Begin water restriction in the morning (typically 7-8 AM) 1
    • No fluid intake allowed throughout the test 1
    • Patient can remain ambulatory but should avoid excessive physical activity 1
  2. Inpatient Overnight Phase:

    • Continue water restriction under medical supervision 1
    • Monitor weight, vital signs, and serum sodium levels regularly 1
    • Collect urine samples every 2-4 hours to measure osmolality 1, 5
  3. Termination Criteria:

    • When one of the following is reached:
      • 3% reduction in body weight 5

      • Urinary specific gravity >1.020 or urinary osmolality >800 mOsm/L 5
      • Intolerable symptoms such as excessive thirst 5
      • Serum sodium exceeds safe levels (>148-150 mmol/L) 6
      • Maximum test duration of 16-18 hours 1, 5
  4. DDAVP Administration:

    • After completing the water deprivation phase, administer desmopressin (DDAVP) 2
    • Collect urine samples at 30,60, and 120 minutes after DDAVP administration 6
    • Measure urine osmolality in each sample 6

Interpretation of Results

  • Primary Polydipsia: Urine osmolality >680-800 mOsm/kg after water deprivation 5, 7
  • Complete Central DI:
    • Urine osmolality remains <300 mOsm/kg after water deprivation 6
    • 50% increase in urine osmolality after DDAVP administration 6

    • Low or undetectable plasma AVP levels despite high serum osmolality 7
  • Partial Central DI:
    • Intermediate urine concentration (300-800 mOsm/kg) after water deprivation 6
    • Significant increase in urine osmolality after DDAVP administration 6
  • Nephrogenic DI:
    • Urine osmolality remains <300 mOsm/kg after water deprivation 6
    • <10% increase in urine osmolality after DDAVP administration 6
    • Elevated plasma AVP levels 1

Safety Considerations

  • Close monitoring of serum sodium is crucial to prevent dangerous hypernatremia 1
  • Have intravenous access available for emergency hydration if needed 1
  • The test should be performed in experienced centers with appropriate supervision 1
  • For patients requiring fasting >4 hours, consider intravenous 5% dextrose in water at maintenance rate if needed 4
  • Monitor for signs of dehydration and electrolyte imbalances throughout the test 1

Alternative Diagnostic Approaches

  • Hypertonic saline infusion test with copeptin measurement is emerging as a potentially safer and more accurate alternative 8, 6
  • Arginine stimulation test with copeptin measurement may also be used as a confirmatory test 2
  • In all three diagnostic approaches, the response to desmopressin remains a key differentiating factor between central and nephrogenic DI 2, 3

References

Research

A COMBINED OUTPATIENT AND INPATIENT OVERNIGHT WATER DEPRIVATION TEST IS EFFECTIVE AND SAFE IN DIAGNOSING PATIENTS WITH POLYURIA-POLYDIPSIA SYNDROME.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2018

Guideline

Diagnóstico y Tratamiento de la Diabetes Insípida Central

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Partial Central Diabetes Insipidus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.